News

Fuel cell company Bloom Energy (NYSE: BE) grew its revenue by 37% in the fourth quarter, a solid improvement from 3.5% growth in the third quarter. The revenue growth was the highest in the last

The crypto market is a volatile place. Some people have made fortunes overnight, while others have lost their life savings just as quickly. But some cryptocurrencies are more volatile than others

The COVID-19 pandemic hit mall owners like Macerich (NYSE: MAC) hard during 2020. Fortunately, Americans eagerly returned to in-person experiences -- including trips to the mall -- in 2021

The popularity of non-fungible tokens (NFTs) is surging higher. As reported by Reuters, DappRadar data shows that sales of NFTs reached $25 billion in 2021. This was a stunning 260-fold

Last year was a record year for single-family rental (SFR) construction, and 2022 may well see more of the same. There's a good reason for that: The market is there, and the appeal is broad.

"There

The Ethereum (CRYPTO: ETH) cryptocurrency carries a total market value of $348 billion today. That's more than 18% of the total cryptocurrency market, which clocked in at $1.89 trillion at 2 p.m. ET

Buy now, pay later company Affirm Holdings (NASDAQ: AFRM) has left many investors scratching their heads and licking their wounds over the past couple of days. The company leaked and then quickly

Controversial meme token Shiba Inu (CRYPTO: SHIB) has enjoyed a rebound in the past few weeks. It traded at a low price of $0.000019 per token in January, and has since soared by more than 57% to

Payment processing leader PayPal (NASDAQ: PYPL) is now down by more than 60% from the highs after a disappointing growth forecast. But is now a good time for long-term investors to take a closer

It's fair to assume a great stock is going to cost more than the average stock on a price-to-earnings ratio basis as well as an absolute basis. The highest echelon of companies seems to seek out the

Many high-growth stocks have been beaten down in the recent market downturn, but insurance technology company Lemonade (NYSE: LMND) has been hit harder than most. In this Motley Fool Live video

With supply chain shortages lingering and the pandemic bringing mounting challenges for companies across a range of industries, one of a variety of trends has emerged: a growing number of companies

Technology stocks have had a difficult time on the market so far in 2022, with the Nasdaq-100 Technology Sector index losing more than 10% of its value year to date over various concerns, especially

Position sizing can be essential to successful investing. You don't need to put a lot of money into a "lottery ticket" type of investment as you stand to lose a lot if that one pick doesn't work

Home prices rose at unprecedented levels in 2021, up somewhere between 16.9% and 20% from 2020 prices, depending on the statistics you look at. It was even more in some hot spots like Miami, where

During the early days of the coronavirus pandemic, markets faced a lot of turbulence, with stocks and other assets selling off hard. To calm markets and ensure the smooth functioning of the

Block (NYSE: SQ), better known as Square, has dramatically underperformed the stock market in the recent downturn, with shares plunging by more than 65% from the 2021 highs. In this Fool Live video

Take any stock and combine the price per share at market close for each of the last 200 days that the stock market was open. Now divide this number by 200. This is the stock's 200-day moving

Early retirement can be the best decision ever -- or a choice you come to regret. The outcome all depends on whether you're really prepared to leave the workforce at a young age or whether doing so

Last month, tech giant Microsoft (NASDAQ: MSFT) announced that it's planning to buy one of the world's largest video game publishers, Activision Blizzard (NASDAQ: ATVI), for roughly $69 billion

Roku (NASDAQ: ROKU) is off to a fumbling start in 2022. Year to date, the stock has tumbled 30%. This poor performance means the stakes are high going into the streaming TV company's fourth-quarter

In this clip from "The Pharma & Biotech Show" on Motley Fool Live, recorded on Feb. 2, Motley Fool contributors Keith Speights and Brian Orelli discuss the recently announced rolling EUA submission

In this clip from "The Pharma & Biotech Show" on Motley Fool Live, recorded on Feb. 2, Motley Fool contributors Brian Orelli and Keith Speights discuss the major lawsuit between Gilead (NASDAQ:

In this clip from "The Pharma & Biotech Show" on Motley Fool Live, recorded on Feb. 2, Motley Fool contributors Keith Speights and Brian Orelli explain why the news of a discontinued drug from the